Pseudoangiomatous stromal hyperplasia: An overview

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 7, 2010, Pages 1070-1074

  Virk, Renu K ^a   Khan, Ashraf ^a  

^a UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CD34 ANTIGEN; PROGESTERONE RECEPTOR; VIMENTIN;

ANGIOSARCOMA; ARTICLE; BREAST DISEASE; BREAST TUMOR; DIFFERENTIAL DIAGNOSIS; FEMALE; HEMANGIOMA; HUMAN; HYPERPLASIA; METABOLISM; PATHOLOGY; STROMA CELL;

ACTINS; ANTIGENS, CD34; BREAST DISEASES; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMANGIOMA; HEMANGIOSARCOMA; HUMANS; HYPERPLASIA; RECEPTORS, PROGESTERONE; STROMAL CELLS; VIMENTIN;

EID: 77954319180     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Leon ME, Leon MA, Ahuja J, Garcia FU. Nodular myofibroblastic stromal hyperplasia of the mammary gland as an accurate name for pseudoangiomatous stromal hyperplasia of the mammary gland. Breast J. 2002;8(5):290-293.
2. Vuitch MF, Rosen PP, Erlandson RA. Pseudoangiomatous hyperplasia of mammary stroma. Hum Pathol. 1986;17(2):185-191.
3. Powell CM, Cranor ML, Rosen PP. Pseudoangiomatous stromal hyperplasia (PASH): a mammary stromal tumor with myofibroblastic differentiation. Am J Surg Pathol. 1995;19(3):270-277.
4. Ferreira M, Albarracin CT, Resetkova E. Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases. Mod Pathol. 2008;21(2):201-207.
5. Wieman SM, Landercasper J, Johnson JM, et al. Tumoral pseudoangiomatous stromal hyperplasia of the breast. Am Surg. 2008;74(12):1211-1214.
6. Milanezi MF, Saggioro FP, Zanati SG, Bazan R, Schmitt FC. Pseudoangiomatous hyperplasia of mammary stroma associated with gynaecomastia. J Clin Pathol. 1998;51(3):204-206.
7. Yoo K, Woo OH, Yong HS, et al. Fast-growing pseudoangiomatous stromal hyperplasia of the breast: report of a case. Surg Today. 2007;37(11):967-970.
8. Teh HS, Chiang SH, Leung JW, Tan SM, Mancer JF. Rapidly enlarging tumoral pseudoangiomatous stromal hyperplasia in a 15-year-old patient: distinguishing sonographic and magnetic resonance imaging findings and correlation with histologic findings. J Ultrasound Med. 2007;26(8):1101-1106.
9. Iancu D, Nochomovitz LE. Pseudoangiomatous stromal hyperplasia: presentation as a mass in the female nipple. Breast J. 2001;7(4):263-265.
10. Lee JS, Oh HS, Min KW. Mammary pseudoangiomatous stromal hyperplasia presenting as an axillary mass. Breast. 2005;14(1):61-64.
11. Tavassoli FA, Devilee P, eds. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003. World Health Organization Classification of Tumours.
12. Anderson C, Ricci A Jr, Pedersen CA, Cartun RW. Immunocytochemical analysis of estrogen and progesterone receptors in benign stromal lesions of the breast: evidence for hormonal etiology in pseudoangiomatous hyperplasia of mammary stroma. Am J Surg Pathol. 1991;15(2):145-149.
13. Zanella M, Falconieri G, Lamovec J, Bittesini L. Pseudoangiomatous hyperplasia of the mammary stroma: true entity or phenotype? Pathol Res Pract. 1998;194(8):535-540.
14. Vogel PM, Georgiade NG, Fetter BF, Vogel FS, McCarty KS Jr. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol. 1981;104(1):23-34.
15. Seidman JD, Borkowski A, Aisner SC, Sun CC. Rapid growth of pseudoangiomatous hyperplasia of mammary stroma in axillary gynecomastia in an immunosuppressed patient. Arch Pathol Lab Med. 1993;117(7):736-738.
16. Rosen PP. Rosen's Breast Pathology, 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2001.
17. Moore T, Lee AH. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast. Histopathology. 2001;38(1):62-67.
18. Damiani S, Peterse L, Eusebi V. Malignant neoplasms infiltrating pseudoangiomatous stromal hyperplasia of the breast: an unrecognized pathway of tumor spread. Histopathology. 2002;41(3):208-215.
19. Hartveit F. Attenuated cells in breast stroma: the missing lymphatic system of the breast. Histopathology. 1990;16(6):533-543.
20. Polger MR, Denison CM, Lester S, Meyer JE. Pseudoangiomatous stromal hyperplasia: mammographic and sonographic appearances. AJR Am J Roentgenol. 1996;166(2):349-352.
21. Mercado CL, Naidrich SA, Hamele-Bena D, Fineberg SA, Buchbinder SS. Pseudoangiomatous stromal hyperplasia of the breast: sonographic features with histopathologic correlation. Breast J. 2004;10(5):427-432.
22. Sasaki Y, Kamata S, Saito K, Nishikawa Y, Ogawa J. Pseudoangiomatous stromal hyperplasia (PASH) of the mammary gland: report of a case. Surg Today. 2008;38(4):340-343.
23. Ibrahim RE, Sciotto CG, Weidner N. Pseudoangiomatous hyperplasia of mammary stroma: some observations regarding its clinicopathologic spectrum. Cancer. 1989;63(6):1154-1160.
24. Comunoǧlu N, Comunoǧlu C, Ilvan S, Calay Z, Müslümanoǧlu M. Mammary pseudoangiomatous stromal hyperplasia composed of predominantly giant cells: an unusual variant. Breast J. 2007;13(6):568-570.
25. Damiani S, Eusebi V. Gynecomastia in type-1 neurofibromatosis with features of pseudoangiomatous stromal hyperplasia with giant cells: report of two cases. Virchows Arch. 2001;438(5):513-516.
26. Levine PH, Nimeh D, Guth AA, Cangiarella JF. Aspiration biopsy of nodular pseudoangiomatous stromal hyperplasia of the breast: clinicopathologic correlates in 10 cases. Diagn Cytopathol. 2005;32(6):345-350.
27. Morgan MB, Pitha JV. Myofibroblastoma of the breast revisited: an etiologic association with androgens? Hum Pathol. 1998;29(4):347-351.
28. Pruthi S, Reynolds C, Johnson RE, Gisvold JJ. Tamoxifen in the management of pseudoangiomatous stromal hyperplasia. Breast J. 2001;7(6):434-439.